Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ) just unveiled an update.
Fisher & Paykel Healthcare Corporation Limited reported a record full-year revenue of $2.02 billion for the financial year ending March 31, 2025, marking a 16% increase from the previous year. The company saw significant growth in its hospital consumables and sleep apnea mask segments, with a net profit after tax rising by 43% to $377.2 million. The company invested heavily in research and development, launching new products and expanding its market presence in the United States. The outlook for the 2026 financial year anticipates further revenue growth and improved gross margins, despite potential impacts from US tariffs.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare is a leading designer, manufacturer, and marketer of products and systems used in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide.
For an in-depth examination of FSPKF stock, go to TipRanks’ Stock Analysis page.